Jonathan Talamo resigned as Ocular Therapeutix Inc.'s chief medical officer, effective June 15.
Discover more about S&P Global’s offerings
Ocular Therapeutix chief medical officer resigns
Insight Weekly: Bank mergers of equals return; energy tops S&P 500; green bond sales to rise
Insight Weekly: US companies boost liquidity; auto insurers hike rates; office sector risk rises
Essential IR Insights Newsletter - Summer July-August 2023
Insight Weekly: Climate law faces hurdles; US borrowing surges; banks revise uninsured deposits
Jonathan Talamo resigned as Ocular Therapeutix Inc.'s chief medical officer, effective June 15.